omeprazole has been researched along with Dementia in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the impact of MHRA DHPCs on prescribing practice in the secondary-care setting, looking specifically at a drug-drug interaction-the concomitant use of clopidogrel and proton pump inhibitors (PPIs) [as omeprazole]-and a drug-disease contraindication-the use of conventional (typical) antipsychotics in dementia." | 3.79 | The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis. ( Coleman, JJ; Dhami, A; Hodson, J; McIlroy, G; Thomas, SK, 2013) |
"Pantoprazole was the most frequently used PPI agent." | 1.91 | Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany. ( Ahn, N; Baumeister, SE; Gerlach, R; Günter, A; Güntner, F; Linseisen, J; Meisinger, C; Nolde, M; Rückert-Eheberg, IM; Tauscher, M; Wawro, N, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Weiss, A | 2 |
Gingold-Belfer, R | 2 |
Boltin, D | 1 |
Beloosesky, Y | 1 |
Koren-Morag, N | 1 |
Meyerovitch, J | 1 |
Sharon, E | 1 |
Schmilovitz-Weiss, H | 2 |
Du, J | 1 |
Lai, Y | 1 |
Zhang, L | 1 |
Ahn, N | 1 |
Wawro, N | 1 |
Baumeister, SE | 1 |
Nolde, M | 1 |
Gerlach, R | 1 |
Tauscher, M | 1 |
Günter, A | 1 |
Güntner, F | 1 |
Rückert-Eheberg, IM | 1 |
Meisinger, C | 1 |
Linseisen, J | 1 |
Thomas, SK | 1 |
Hodson, J | 1 |
McIlroy, G | 1 |
Dhami, A | 1 |
Coleman, JJ | 1 |
5 other studies available for omeprazole and Dementia
Article | Year |
---|---|
Chronic omeprazole use in the elderly is associated with decreased risk of dementia and cognitive decline.
Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Omeprazole; Proton Pump Inhibitors; Retrospective Stu | 2022 |
Chronic omeprazole use in the elderly: Is it related to the risk of dementia and cognitive decline?
Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Omeprazole | 2022 |
Author's Reply: "Chronic omeprazole use in the elderly: Is it related to the risk of dementia and cognitive decline?"
Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Omeprazole | 2022 |
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
Topics: Cognitive Dysfunction; Dementia; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors | 2023 |
The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Clopidogrel; Communication; Dementia; | 2013 |